Skip to main content
Top
Published in: International Urology and Nephrology 2/2016

01-02-2016 | Urology - Original Paper

Does the presence of vesicoureteral reflux affect in vitro uropathogenic E. coli growth rate in urine?

Authors: Alper Soylu, Meral Karaman, Demet Alaygut, Seçil Arslansoyu Çamlar, Mehmet Türkmen, Salih Kavukçu

Published in: International Urology and Nephrology | Issue 2/2016

Login to get access

Abstract

Background

Uroepithelial molecules like uroplakins are involved both in the development of urinary tract and in colonization, attachment and invasion of uropathogenic Escherichia coli (UPEC). Uroplakin disorders are also associated with vesicoureteral reflux (VUR). We hypothesized that urine contents, as well as urinary flow, may be altered in VUR, and aimed to determine whether in vitro UPEC growth is increased in urine from the refluxing systems.

Methods

Children evaluated by voiding cystourethrography for UTI were enrolled. Groups 1 and 2 included children with and without VUR, respectively. Sterile urine samples were obtained from all patients, and 2 × 102 cfu/mL UPEC suspension was inoculated into these samples. After incubation for 24 h, colony counts were assessed. Both groups were compared for UPEC growth and colony counts.

Results

Forty-two urine samples were included (21 in each group). UPEC was cultured in 9 (43 %) and 3 (14 %) samples in Groups 1 and 2, respectively (p = 0.040, OR 4.5). Colony counts were similar in both groups (log x; 2.36 ± 0.25 vs. 2.37 ± 0.12, p = 0.923).

Conclusion

Inoculation of 2 × 102 cfu UPEC resulted in growth in almost half of the urine samples from refluxing systems, while UPEC growth was inhibited in most urine samples from non-refluxing systems suggesting that urine contents in refluxing units change in such a way that UPEC growth is facilitated.
Literature
1.
go back to reference Lopez PJ, Celis S, Reed F, Zubieta R (2014) Vesicoureteral reflux: current management in children. Curr Urol Rep 15:447PubMedCrossRef Lopez PJ, Celis S, Reed F, Zubieta R (2014) Vesicoureteral reflux: current management in children. Curr Urol Rep 15:447PubMedCrossRef
2.
go back to reference Lebowitz RL, Olbing H, Parkkulainen KV, Smellie JM, Tamminen-Möbius TE (1985) International system of radiographic grading of vesicoureteric reflux. International reflux study in children. Pediatr Radiol 15:105–109PubMedCrossRef Lebowitz RL, Olbing H, Parkkulainen KV, Smellie JM, Tamminen-Möbius TE (1985) International system of radiographic grading of vesicoureteric reflux. International reflux study in children. Pediatr Radiol 15:105–109PubMedCrossRef
3.
go back to reference Lüthje P, Brauner A (2014) Virulence factors of uropathogenic E. coli and their interaction with the host. Adv Microb Physiol 65:337–372PubMedCrossRef Lüthje P, Brauner A (2014) Virulence factors of uropathogenic E. coli and their interaction with the host. Adv Microb Physiol 65:337–372PubMedCrossRef
5.
go back to reference Jenkins D, Woolf AS (2007) Uroplakins: new molecular players in the biology of urinary tract malformations. Kidney Int 71:195–200PubMedCrossRef Jenkins D, Woolf AS (2007) Uroplakins: new molecular players in the biology of urinary tract malformations. Kidney Int 71:195–200PubMedCrossRef
6.
go back to reference Bulut IK, Mir S, Berdeli A, Sozeri B (2014) The predictive value of urinary UP Ib mRNA levels in VUR and recurrent urinary tract infections. Clin Nephrol 81:152–158PubMedCrossRef Bulut IK, Mir S, Berdeli A, Sozeri B (2014) The predictive value of urinary UP Ib mRNA levels in VUR and recurrent urinary tract infections. Clin Nephrol 81:152–158PubMedCrossRef
7.
go back to reference Hull RA, Hull SI (1997) Nutritional requirements for growth of uropathogenic Escherichia coli in human urine. Infect Immun 65:1960–1961PubMedPubMedCentral Hull RA, Hull SI (1997) Nutritional requirements for growth of uropathogenic Escherichia coli in human urine. Infect Immun 65:1960–1961PubMedPubMedCentral
8.
go back to reference Firinci F, Soylu A, Ozturk C, Gulay Z, Demir BK, Turkmen M, Kavukcu S (2014) Hyperbilirubinemia and urinary tract infection: the effect of indirect hyperbilirubinemia on the in vitro growth of uropathogen Escherichia coli in newborn urine. Ren Fail 36:55–57PubMedCrossRef Firinci F, Soylu A, Ozturk C, Gulay Z, Demir BK, Turkmen M, Kavukcu S (2014) Hyperbilirubinemia and urinary tract infection: the effect of indirect hyperbilirubinemia on the in vitro growth of uropathogen Escherichia coli in newborn urine. Ren Fail 36:55–57PubMedCrossRef
9.
go back to reference Chowdhury P, Scake SH, Sheerin NS (2004) Functions of the renal tract epithelium in coordinating the innate immune response to infection. Kidney Int 66:1334–1340PubMedCrossRef Chowdhury P, Scake SH, Sheerin NS (2004) Functions of the renal tract epithelium in coordinating the innate immune response to infection. Kidney Int 66:1334–1340PubMedCrossRef
10.
go back to reference Hidas G, Billimek J, Nam A, Soltani T, Kelly MS, Selby B, Dorgalli C, Wehbi E, McAleer I, McLorie G, Greenfield S, Kaplan SH, Khoury AE (2015). Predicting the risk for breakthrough urinary tract infections: primary vesicoureteral reflux. J Urol. doi: 10.1016/j.juro.2015.06.019 [Epub ahead of print] Hidas G, Billimek J, Nam A, Soltani T, Kelly MS, Selby B, Dorgalli C, Wehbi E, McAleer I, McLorie G, Greenfield S, Kaplan SH, Khoury AE (2015). Predicting the risk for breakthrough urinary tract infections: primary vesicoureteral reflux. J Urol. doi: 10.​1016/​j.​juro.​2015.​06.​019 [Epub ahead of print]
11.
go back to reference Mak RH, Kuo HJ (2006) Pathogenesis of urinary tract infection: an update. Curr Opin Pediatr 18:148–152PubMedCrossRef Mak RH, Kuo HJ (2006) Pathogenesis of urinary tract infection: an update. Curr Opin Pediatr 18:148–152PubMedCrossRef
12.
go back to reference Joshi N, Caputo GM, Weitekamp MR, Karchmer AW (1999) Infections in patients with diabetes mellitus. N Engl J Med 341:1906–1912PubMedCrossRef Joshi N, Caputo GM, Weitekamp MR, Karchmer AW (1999) Infections in patients with diabetes mellitus. N Engl J Med 341:1906–1912PubMedCrossRef
13.
go back to reference Uto I, Ishimatsu T, Hirayama H, Ueda S, Nishi K, Tsuruta J, Kambara T (1991) Urinary Tamm-Horsfall protein excretion in patients with primary vesicoureteral reflux. Eur Urol 19:315–318PubMed Uto I, Ishimatsu T, Hirayama H, Ueda S, Nishi K, Tsuruta J, Kambara T (1991) Urinary Tamm-Horsfall protein excretion in patients with primary vesicoureteral reflux. Eur Urol 19:315–318PubMed
14.
go back to reference Dalirani R, Mahyar A, Sharifian M, Mohkam M, Esfandiar N, Ghehsareh Ardestani A (2014) The value of direct radionuclide cystography in the detection of vesicoureteral reflux in children with normal voiding cystourethrography. Pediatr Nephrol 29:2341–2345PubMedCrossRef Dalirani R, Mahyar A, Sharifian M, Mohkam M, Esfandiar N, Ghehsareh Ardestani A (2014) The value of direct radionuclide cystography in the detection of vesicoureteral reflux in children with normal voiding cystourethrography. Pediatr Nephrol 29:2341–2345PubMedCrossRef
16.
go back to reference Marild S, Hansson S, Jodal U, Oden A, Svedberg K (2004) Protective effect of breastfeeding against urinary tract infection. Acta Paediatr 93:164–168PubMedCrossRef Marild S, Hansson S, Jodal U, Oden A, Svedberg K (2004) Protective effect of breastfeeding against urinary tract infection. Acta Paediatr 93:164–168PubMedCrossRef
17.
go back to reference Pomeranz A, El-Khayam A, Korzets Z, Kessler OJ, Godfrey L, Katz B, Wolach B (2000) A bioassay evaluation of the urinary antibacterial efficacy of low dose prophylactic antibiotics in children with vesicoureteral reflux. J Urol 164:1070–1073PubMedCrossRef Pomeranz A, El-Khayam A, Korzets Z, Kessler OJ, Godfrey L, Katz B, Wolach B (2000) A bioassay evaluation of the urinary antibacterial efficacy of low dose prophylactic antibiotics in children with vesicoureteral reflux. J Urol 164:1070–1073PubMedCrossRef
Metadata
Title
Does the presence of vesicoureteral reflux affect in vitro uropathogenic E. coli growth rate in urine?
Authors
Alper Soylu
Meral Karaman
Demet Alaygut
Seçil Arslansoyu Çamlar
Mehmet Türkmen
Salih Kavukçu
Publication date
01-02-2016
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 2/2016
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-015-1168-9

Other articles of this Issue 2/2016

International Urology and Nephrology 2/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine